Patent classifications
A23V2250/314
Nutritional composition
The present invention provides nutritional compositions that are employed as oral supplementation to the human diet. The compositions of the present invention provide for supplementation to the diet of the cancer patient, as well as preventative dietary supplementation aimed at supporting the human immune system for those not currently suffering from cancer. The present invention is comprised of specific combinations of selected forms selenium, chromium, and molybdenum in c combination with a fish oil.
Nutritional composition
The present invention provides nutritional compositions that are employed as oral supplementation to the human diet. The compositions of the present invention provide for supplementation to the diet of the cancer patient, as well as preventative dietary supplementation aimed at supporting the human immune system for those not currently suffering from cancer. The present invention is comprised of specific combinations of selected forms selenium, chromium, and molybdenum in c combination with a fish oil.
Oral lipid supplements for treating pain and fibromyalgia
A method of oral delivery of phospholipid/inulin compositions comprising capsules, tablets, chewable wafers or powdered material in a liquid carrier in quantities effective for treating systemic pain from fibromyalgia. The compositions further including effective amounts of caffeine also reduces fatigue and enhances alertness and focus.
Oral lipid supplements for treating pain and fibromyalgia
A method of oral delivery of phospholipid/inulin compositions comprising capsules, tablets, chewable wafers or powdered material in a liquid carrier in quantities effective for treating systemic pain from fibromyalgia. The compositions further including effective amounts of caffeine also reduces fatigue and enhances alertness and focus.
DIETARY SUPPLEMENT COMPOSITIONS FOR TREATING NEUROLOGICAL DISORDERS, AND METHODS OF TREATING NEUROLOGICAL DISORDERS USING SAME
A dietary supplement composition, which may be used for treating neurological and developmental disorders in human subjects, includes trans-resveratrol, ginkgo biloba, Coenzyme Q10, and natural flavonoids blend, in which a content of the trans-resveratrol is about 250 mg; a content of the ginkgo biloba is about 120 mg; a content of the Coenzyme Q10 is about 100 mg; and a content of the natural flavonoids blend is about 256 mg. The natural flavonoids blend may include quercetin, fisetin derived from strawberries; and anthocyanidin and anthocyanin derived from European blueberry extracts. The dietary supplement composition according another aspect includes at least three of trans-resveratrol, ginkgo biloba, Coenzyme Q10, and natural flavonoids blend. The dietary supplement compositions further includes zinc gluconate, cyanocbalamin and taurine. Such dietary supplement compositions are effective and efficient for treating subjects having neurological disorders including autism spectrum disorders, and Alzheimer's disease.
ENERGY SUPPLEMENT
Compositions for energy supplements are provided containing L-tryptophan in an amount of 15-28%, CoQ10 in an amount of 7-15%, pyrroloquinaline quinone in an amount of 0.4-5%, niacinamide in an amount of 2-9%, niacin in an amount of 0.4-5%, magnesium in an amount of 4-20%, acetyl-L-carnitine in an amount of 10-28%, alpha liolic acid in an amount of 10-30%, N-acetyl cysteine in an amount of 4-15%, and resveratrol an amount of 3-14% administered with a daily supplement of D-Ribose in an amount of 500 mg to 15,000 mg. The compositions providing an unexpected increase in mitochondrial biogenesis, activity, and preservation and therefore increased energy availability.
ENERGY SUPPLEMENT
Compositions for energy supplements are provided containing L-tryptophan in an amount of 15-28%, CoQ10 in an amount of 7-15%, pyrroloquinaline quinone in an amount of 0.4-5%, niacinamide in an amount of 2-9%, niacin in an amount of 0.4-5%, magnesium in an amount of 4-20%, acetyl-L-carnitine in an amount of 10-28%, alpha liolic acid in an amount of 10-30%, N-acetyl cysteine in an amount of 4-15%, and resveratrol an amount of 3-14% administered with a daily supplement of D-Ribose in an amount of 500 mg to 15,000 mg. The compositions providing an unexpected increase in mitochondrial biogenesis, activity, and preservation and therefore increased energy availability.
NUTRITIONAL COMPOSITION
The present invention provides nutritional compositions that are employed as oral supplementation to the human diet. The compositions of the present invention provide for supplementation to the diet of the cancer patient, as well as preventative dietary supplementation aimed at supporting the human immune system for those not currently suffering from cancer. The present invention is comprised of specific combinations of selected forms selenium. chromium, and molybdenum in c combination with a fish oil.
NUTRITIONAL COMPOSITION
The present invention provides nutritional compositions that are employed as oral supplementation to the human diet. The compositions of the present invention provide for supplementation to the diet of the cancer patient, as well as preventative dietary supplementation aimed at supporting the human immune system for those not currently suffering from cancer. The present invention is comprised of specific combinations of selected forms selenium. chromium, and molybdenum in c combination with a fish oil.
Compositions containing non-polar compounds
Provided herein are compositions and methods for preparing foods and beverages that contain additives, such as nutraceuticals, pharmaceuticals, and supplements, such as essential fatty acids, including omega-3 fatty acids, omega-6 fatty acids, conjugated fatty acids, and other fatty acids; phytochemicals, including phytosterols; other oils; and coenzymes, including Coenzyme Q10, and other oil-based additives.